All In MedTech

FDA Clearance Tracker · P140004-S004

Superion® Interspinous Spacer

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Oct 11, 2016 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Oct 11, 2016

Approved

Time to decision

78 days

Received Jul 25, 2016. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P140004-S004
Device name
Superion® Interspinous Spacer
Applicant location
Valencia, CA
Received
Jul 25, 2016
Decided
Oct 11, 2016
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P140004

Device type

Device class
Class III

Every decision under product code NQO

FDA's approval statement

As written in FDA's record.

Approval for a design modification to the Superion® implants and new labeling.

Source documents

Other decisions for Boston Scientific Neuromodulation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.